Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY18.39 CNY
Change Today +0.24 / 1.32%
Volume 20.2M
002118 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

jilin zixin pharmaceutical-a (002118) Snapshot

Open
CNY18.15
Previous Close
CNY18.15
Day High
CNY18.75
Day Low
CNY18.05
52 Week High
03/5/15 - CNY19.09
52 Week Low
03/31/14 - CNY11.02
Market Cap
9.4B
Average Volume 10 Days
17.6M
EPS TTM
CNY0.09
Shares Outstanding
513.0M
EX-Date
03/23/15
P/E TM
205.2x
Dividend
CNY0.04
Dividend Yield
0.21%
Current Stock Chart for JILIN ZIXIN PHARMACEUTICAL-A (002118)

Related News

No related news articles were found.

jilin zixin pharmaceutical-a (002118) Related Businessweek News

No Related Businessweek News Found

jilin zixin pharmaceutical-a (002118) Details

Jilin Zixin Pharmaceutical Industrial Co., Ltd researches, develops, manufactures, and sells traditional Chinese patent drugs in China. It is also involved the plantation of medicinal materials. The company provides Huoxue Tongmai tablets, Simiao pills, Fufang Yigan tablets, Xingnao Zaizao capsules, Shen Fukang capsules, Bushen Anshen oral solutions, Liuwei Dihuang capsules, ginseng products, Shexiang Jiegu capsules, and other products. It primarily offers drugs for the treatment of cardiovascular and cerebrovascular diseases, digestive system diseases, and bone fractures. The company is based in Tonghua, China.

jilin zixin pharmaceutical-a (002118) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jilin zixin pharmaceutical-a (002118) Key Developments

Jilin Zixin Pharmaceutical Industrial Co.,Ltd, 2014 Earnings Call, Mar 03, 2015

Jilin Zixin Pharmaceutical Industrial Co.,Ltd, 2014 Earnings Call, Mar 03, 2015

Jilin Zixin Pharmaceutical Industrial Co.,Ltd Proposes Amendments to Articles of Association

Jilin Zixin Pharmaceutical Industrial Co.,Ltd will propose amendments to the articles of association of the company, at the annual general meeting to be held on March 10, 2015.

Jilin Zixin Pharmaceutical Industrial Co.,Ltd, Annual General Meeting, Mar 10, 2015

Jilin Zixin Pharmaceutical Industrial Co.,Ltd, Annual General Meeting, Mar 10, 2015., at 15:00 China Standard Time. Agenda: To discuss 2014 work report of the board of directors; to discuss 2014 work report of the supervisory committee; to discuss 2014 annual report and its summary; to discuss 2014 financial resolution report; to discuss 2014 profit distribution plan; to discuss special report on storage and use of raised funds in 2014; to consider report on the use of previously raised funds; to consider reappointment of audit firm; to permanently replenish working capital with single surplus raised funds; and to consider change of the business scope of the company and amendments to the articles of association of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002118:CH CNY18.39 CNY +0.24

002118 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002118.
View Industry Companies
 

Industry Analysis

002118

Industry Average

Valuation 002118 Industry Range
Price/Earnings 100.0x
Price/Sales 12.0x
Price/Book 4.7x
Price/Cash Flow 197.0x
TEV/Sales 9.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JILIN ZIXIN PHARMACEUTICAL-A, please visit www.jilinzixin.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.